17
3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3175 | LDHA-IN-4 | AZ 33,AZ-33,LDHA Inhibitor,AZ33 | Dehydrogenase |
LDHA-IN-4 (AZ33) is an LDHA inhibitor. Binding affinity to 6-His-tagged human LDHA (2 to 322 amino acid residue) expressed in Escherichia coli BL21 (DE3) cells by SPR analysis with an active value of 0.093 μM. | |||
T39805 | LDHA-IN-3 | PSTMB,1-(phenylseleno)-4-(trifluoromethyl) benzene | Dehydrogenase |
LDHA-IN-3 (1-(phenylseleno)-4-(trifluoromethyl) benzene) is a potent non-competitive lactate dehydrogenase (LDHA) inhibitor with an IC50 value of 145.2 nM.LDHA-IN-3 is a selenobenzene compound that can be used in cancer ... | |||
T15362 | FX-11 | LDHA Inhibitor FX11 | Dehydrogenase |
FX-11 (LDHA Inhibitor FX11) is A potent, selective and competitive specific inhibitor of lactate dehydrogenase A (LDHA) with a Ki of 8 μM. FX-11 can activate PKM2 (pyruvate kinase M2). FX-11 can reduce ATP levels, induce... | |||
T73222 | LDHA-IN-5 | ||
LDHA-IN-5 is a novel and potent inhibitor targeting both glycolate oxidase (GO) and lactate dehydrogenase A (LDHA), designed for the treatment of primary hyperoxaluria. | |||
T60995 | LDHA/PDKs-IN-2 | ||
LDHA/PDKs-IN-2 (compound 20k) is a potent LDHA and PDKs dual inhibitor with IC50 values of 0.7 and 1.6 μM, respectively. LDHA/PDKs-IN-2 increases oxygen consumption as well as decreases the lactate formation. LDHA/PDKs-I... | |||
T61339 | LDHA/PDKs-IN-1 | ||
LDHA/PDKs-IN-1 (compound 20e) is a highly effective dual inhibitor of PDKs and LDHA, displaying IC50 values of 0.8 μM and 0.15 μM, respectively. It significantly suppresses A549 cell proliferation (EC50 = 13.2 μM), reduc... | |||
T15435 | GSK2837808A | Dehydrogenase | |
GSK2837808A is a potent and selective inhibitor of lactate dehydrogenase A (LDHA) (IC50s: 1.9 and 14 nM for LDHA and LDHB, respectively). | |||
T4295 | (R)-GNE-140 | GNE-140 | Dehydrogenase |
(R)-GNE-140 (GNE-140) is an effective LDHA/LDHB inhibitor (IC50s: 3/5 nM) and is 18-fold more potent than S enantiomer. | |||
T11829 | LDH-IN-1 | Dehydrogenase | |
LDH-IN-1 is a pyrazole-based human lactate dehydrogenase (LDH) inhibitor(IC50s of 32 and 27 nM for LDHA and LDHB, respectively). | |||
T19831 | Sodium Oxamate | oxamate sodium,Oxamic acid sodium salt,Aminooxoacetic acid sodium salt,SO | Apoptosis , Dehydrogenase , CDK |
Sodium Oxamate (Oxamic acid sodium salt) is an LDH inhibitor that specifically inhibits LDHA. Sodium Oxamate has antitumor activity and induces cell cycle arrest and apoptosis. | |||
T22336 | Galloflavin | Dehydrogenase | |
Galloflavin inhibits both the A and B isoforms of lactate dehydrogenase with Ki of 5.46 µM and 15.06 µM, respectively. Galloflavin is also a potential anticancer agent. | |||
T24530 | NHI-2 | NHI 2 | |
NHI-2 is an inhibitor of LDHA that acts by reducing lactate production in HeLa cells. | |||
T27421 | GNE-140 racemic | GNE-140,GNE 140,GNE140 | |
GNE-140 racemic is a potent lactate dehydrogenase (LDHA) inhibitor. | |||
T13450L | GNE-140 racemate | GNE-140 (racemate) | Others |
GNE-140 is a potent inhibitor of lactate dehydrogenase A (LDHA). GNE-140 is a racemate mixture of (R)-GNE-140 and (S)-GNE-140. | |||
T79874 | CHK-336 | ||
CHK-336 (Example 1), an orally active LDHA inhibitor (IC50 <1 nM), suppresses lactate production in mouse hepatocytes and is applicable in hyperoxaluria research [1]. | |||
T79204 | Anticancer agent 122 | ||
Anticancer agent 122, a potent inhibitor of human lactate dehydrogenase A (h LDHA), exhibits significant anticancer activities, rendering it suitable for use in cancer research [1]. | |||
T81747 | MS6105 | PROTACs | |
MS6105 is a chimeric LDH protein hydrolysis-targeted PROTAC that degrades LDHA and LDHB efficiently, with its activity contingent on both time and the ubiquitin-proteasome system, exhibiting anticancer properties [1]. Ad... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00724 | LDHA Protein, Human, Recombinant (His) | Human | E. coli |
L-Lactate Dehydrogenase A Chain (LDHA) is an enzyme that catalyzes the conversion of L-lactate and NAD+ to pyruvate and NADH in the final step of anaerobic glycolysis. LDHA contains an N-terminal coenzyme binding region,... | |||
TMPY-04241 | LDHA Protein, Rat, Recombinant (His) | Rat | E. coli |
LDHA Protein, Rat, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 38.7 kDa and the accession number is B5DEN4. | |||
TMPY-00010 | LDHA Protein, Mouse, Recombinant (His) | Mouse | E. coli |
LDHA Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 36.5 kDa and the accession number is P06151. |